Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 395

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 395
---
 the total
Public Shares of the Company outstanding prior to the Redemption Date. Following the redemption, 5,295,527 Public Shares were outstanding.

At the special meeting of the
stockholders held on June 9, 2025 (the “Special Meeting”), the Company’s stockholders voted to approve the proposals
outlined in the final prospectus and definitive proxy statement filed by the Company with the U.S. Securities and Exchange Commission
(the “SEC”) on May 15, 2025 (the “Proxy Statement/Prospectus”), including, among other things, the adoption
of the Merger Agreement and approval of the transactions contemplated thereby, including the merger of Merger Sub with and into Profusa,
with Profusa continuing as the surviving corporation and as a wholly-owned subsidiary of the Company (the “Merger”), and the
issuance of the Company’s common stock as consideration thereunder (together with the other transactions contemplated by the Merger
Agreement, the “Business Combination”).

On July 11, 2025 (the
“Closing Date”), the Company closed the Business Combination with Profusa. As a result of the Business Combination, the Company
owns 100% of the outstanding common stock of Profusa.

In connection with the closing
of the Business Combination, the Company changed its name from “NorthView Acquisition Corporation” to “Profusa, Inc.”

Business Prior to the Business Combination

On December 22, 2021,
the Company consummated its Initial Public Offering (“IPO”) of 18,975,000 units (the “Units”), which included
2,475,000 Units issued pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists
of one share of common stock of the Company, par value $0.0001 per share, one right (the “Rights”), and one-half of one redeemable
warrant of the Company (the “Warrants”). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of
common stock. Each Warrant entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment.
The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $189,750,000.

Simultaneously with the closing
of the IPO, the Company completed the private sale of an aggregate of 7,347